Prada, P. O., Ropelle, E. R., Mourão, R. H., de Souza, C. T., Pauli, J. R., Cintra, D. E., . . . Saad, M. J. (2017). Statement of Retraction. EGFR Tyrosine Kinase Inhibitor (PD153035) Improves Glucose Tolerance and Insulin Action in High-Fat Diet–Fed Mice. Diabetes 2009;58: 2910–2919. DOI: 10.2337/db08-0506. PMID: 19696185. Diabetes.
シカゴスタイル引用形Prada, Patricia O., et al. "Statement of Retraction. EGFR Tyrosine Kinase Inhibitor (PD153035) Improves Glucose Tolerance and Insulin Action in High-Fat Diet–Fed Mice. Diabetes 2009;58: 2910–2919. DOI: 10.2337/db08-0506. PMID: 19696185." Diabetes 2017.
MLA引用形式Prada, Patricia O., et al. "Statement of Retraction. EGFR Tyrosine Kinase Inhibitor (PD153035) Improves Glucose Tolerance and Insulin Action in High-Fat Diet–Fed Mice. Diabetes 2009;58: 2910–2919. DOI: 10.2337/db08-0506. PMID: 19696185." Diabetes 2017.